PROXY STATEMENT

Company

Sonoma Pharmaceuticals, Inc.

Filed

July 27, 2017

Period of Report

September 8, 2017

Accession Number

0001683168-17-001877

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →